[Are we ripe for preventive percutaneous coronary interventions?]
- PMID: 40417151
- PMCID: PMC12097337
- DOI: 10.24875/RECIC.M24000483
[Are we ripe for preventive percutaneous coronary interventions?]
Conflict of interest statement
CONFLICTO DE INTERESES: E. Kedhi declara haber recibido subvenciones en materia de investigación institucional de Medtronic y Abbott y ser proctor de Abbott.
Similar articles
-
Preventive percutaneous coronary intervention versus optimal medical therapy alone for the treatment of vulnerable atherosclerotic coronary plaques (PREVENT): a multicentre, open-label, randomised controlled trial.Lancet. 2024 May 4;403(10438):1753-1765. doi: 10.1016/S0140-6736(24)00413-6. Epub 2024 Apr 8. Lancet. 2024. PMID: 38604213 Clinical Trial.
-
[Percutaneous coronary interventions without on-site cardiac surgical backup].Med Arh. 2009;63(3):166-70. Med Arh. 2009. PMID: 20088166 Bosnian.
-
Intravascular ultrasound to guide percutaneous coronary interventions: an evidence-based analysis.Ont Health Technol Assess Ser. 2006;6(12):1-97. Epub 2006 Apr 1. Ont Health Technol Assess Ser. 2006. PMID: 23074482 Free PMC article.
-
2018 Joint European consensus document on the management of antithrombotic therapy in atrial fibrillation patients presenting with acute coronary syndrome and/or undergoing percutaneous cardiovascular interventions: a joint consensus document of the European Heart Rhythm Association (EHRA), European Society of Cardiology Working Group on Thrombosis, European Association of Percutaneous Cardiovascular Interventions (EAPCI), and European Association of Acute Cardiac Care (ACCA) endorsed by the Heart Rhythm Society (HRS), Asia-Pacific Heart Rhythm Society (APHRS), Latin America Heart Rhythm Society (LAHRS), and Cardiac Arrhythmia Society of Southern Africa (CASSA).Europace. 2019 Feb 1;21(2):192-193. doi: 10.1093/europace/euy174. Europace. 2019. PMID: 30052888 Review.
-
Preventive versus culprit-only percutaneous coronary intervention in ST-elevation myocardial infarction patients with multivessel disease: a meta-analysis.J Interv Cardiol. 2015 Feb;28(1):1-13. doi: 10.1111/joic.12167. J Interv Cardiol. 2015. PMID: 25689544 Review.
References
-
- 2. Stone GW, Maehara A, Lansky AJ, et al. PROSPECT Investigators. A prospective natural-history study of coronary atherosclerosis. N Engl J Med. 2011;364:226-235. - PubMed
- Stone GW, Maehara A, Lansky AJ, et al. PROSPECT Investigators. A prospective natural-history study of coronary atherosclerosis. N Engl J Med. 2011;364:226–235. - PubMed
-
- 3. Kedhi E, Berta B, Roleder T, Hermanides RS, et al. Thin-cap fibroatheroma predicts clinical events in diabetic patients with normal fractional flow reserve:the COMBINE OCT-FFR trial. Eur Heart J. 2021;42:4671-4679. - PubMed
- Kedhi E, Berta B, Roleder T, Hermanides RS, et al. Thin-cap fibroatheroma predicts clinical events in diabetic patients with normal fractional flow reserve: the COMBINE OCT-FFR trial. Eur Heart J. 2021;42:4671–4679. - PubMed
-
- 4. Fabris E, Berta B, Roleder T, et al. Thin-Cap Fibroatheroma Rather Than Any Lipid Plaques Increases the Risk of Cardiovascular Events in Diabetic Patients:Insights from the COMBINE OCT-FFR Trial. Circ Cardiovasc Interv. 2022;15:e011728. - PubMed
- Fabris E, Berta B, Roleder T, et al. Thin-Cap Fibroatheroma Rather Than Any Lipid Plaques Increases the Risk of Cardiovascular Events in Diabetic Patients: Insights from the COMBINE OCT-FFR Trial. Circ Cardiovasc Interv. 2022;15:e011728. - PubMed
-
- 5. Prati F, Romagnoli E, Gatto L, et al. Relationship between coronary plaque morphology of the left anterior descending artery and 12 months clinical outcome:the CLIMA study. Eur Heart J. 2020;41:383-391. - PubMed
- Prati F, Romagnoli E, Gatto L, et al. Relationship between coronary plaque morphology of the left anterior descending artery and 12 months clinical outcome: the CLIMA study. Eur Heart J. 2020;41:383–391. - PubMed
Publication types
LinkOut - more resources
Full Text Sources